Non-Fish Omega 3 Supplements Market

Global Non-Fish Omega 3 Supplements Market Outlook (2023 to 2033)

A newly released non-fish omega-3 supplement market analysis report by Fact.MR reveals that global sales of non-fish omega-3 supplements in 2022 were held at US$ 212.9 million. With 9.4% projected growth from 2023 to 2033, the market is expected to reach a valuation of $569.2 million by the end of the forecast period.

Non-fish omega-3 capsule supplements is expected to generate significant revenue with a projected CAGR of over 9% from 2023 to 2033.

Report Attributes	Details
Global Non-Fish Omega 3 Supplements Market Size (2022)	US$ 212.9 million
Global Non-Fish Omega 3 Supplements Market Size (2033)	US$ 569.2 million
Global Non-Fish Omega 3 Supplements Market CAGR (2023 to 2033)	9.4%
U.S. Non-Fish Omega 3 Supplements Market CAGR (2023 to 2033)	9.2%
Key Companies Covered	Croda International Plc. Natural Products Drugs GmbH Hero Nutritionals LLC Koninklijke DSM N.V. Cargill, Inc. Epax Norway AS Arista Industries Inc. Barleans Organic Oils LLC Algaecytes Limited Cellana Inc. AlgiSys Denomega Nutritional Oils

Revenue of Non-Fish Omega 3 Supplements Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the research on the non-fish omega-3 supplements market by Fact.MR, a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 8.2% CAGR. With an absolute dollar opportunity of US$ 337.8 million, the market is projected to reach a valuation of US$ 569.2 million by 2033.

What are the Key Drivers Influencing the Market Expansion?

Non-fish Omega-3 supplements are dietary supplements derived from sources other than fish but still contain omega-3 fatty acids, which are essential polyunsaturated fatty acids known for their numerous health benefits. These supplements typically contain omega-3 fatty acids such as alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), which are commonly found in fish-based sources like fish oil but are sourced from alternative plant-based or microalgae-based sources.

In 2019, global algae supplement sales were valued at around US$ 1.1 billion and were projected to reach about US$ 3.8 billion by 2027, with a CAGR of 15.8% during the forecast period. Algae is a rich source of omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are the same types of omega-3s found in fish oil.

Non-fish omega-3 supplements derived from algae have gained popularity as a sustainable and plant-based alternative to traditional fish oil supplements. The growing demand for algae supplements helps to promote the growth of the non-fish omega-3 supplement market.

In 2020, global omega-3 supplements sales were valued at around US$ 4.89 billion and are projected to reach US$ 7.50 billion by 2027, growing at a CAGR of 6.3% during the forecast year.

Omega-3 supplements are known for their numerous health benefits, including supporting heart health, brain function, eye health, and joint health. As awareness of these health benefits increases, more consumers are seeking Omega-3 supplements as part of their proactive approach to maintain overall health. Non-fish Omega-3 supplements provide an attractive option for those who may have dietary restrictions or allergies to fish but still wish to obtain the health benefits associated with Omega-3s.

Region-Wise Analysis

Which Region is projected to Offer Significant growth in the Market?

North America is a prominent shareholder in the non-fish omega 3 supplements market with a market size of US$ 59.6 million in 2022. It is projected that the region will have a worth of US$ 159.3 million by 2033.

In 2019, dietary supplement sales in Canada was valued at around US$ 5.5 billion and is projected to reach around US$ 8.6 billion by 2025, growing at a CAGR of 7.4% during the forecast period. Consumer preferences for natural and organic products, increased focus on preventive healthcare, and growing interest in personalized nutrition drives the growth of the dietary supplements market. The growing need for plant-based and vegan products helps the growth of Non-fish omega-3 supplements market in the region.

Country-Wise Analysis

United States Non-Fish Omega 3 Supplements Market Analysis:

The market in the United States is expected to grow to be worth US$ 137.4 million by 2033, with an absolute dollar growth of US$ 80.4 million from 2023 to 2033. The market in the country has grown at a CAGR of 8% from 2018 to 2022 and is expected to grow at a CAGR of 9.2% from 2023 to 2033.

In 2021, around 3 million adults in the United States were diagnosed with IBD, which includes both Crohn's disease and ulcerative colitis. The annual incidence of IBD in the United States was estimated to be around 16-18 new cases per 100,000 people for Crohn's disease and 10–12 new cases per 100,000 people for ulcerative colitis.

Omega-3 fatty acids are a type of polyunsaturated fatty acid that have been studied for their potential benefits in inflammatory bowel disease (IBD), which includes conditions such as Crohn's disease and ulcerative colitis. Non-Fish Omega 3 Supplements are derived from plant sources such as flaxseed, chia seeds, and algae. The increasing prevalence of inflammatory bowel disease is expected to contribute to market growth in the upcoming years.

United Kingdom Non-Fish Omega 3 Supplements Market Analysis:

The non-fish omega 3 supplements market size in the United Kingdom is expected to grow to be worth US$ 20.9 million by 2033, with an absolute dollar growth of US$ 11.6 million. The market in the country has grown at a CAGR of 7.1% from 2018 to 2022 and is expected to grow at a CAGR of 8.5% from 2023 to 2033.

In 2021, around 3.9 million people in the UK will have been diagnosed with diabetes, with majority of them having type 2 diabetes. This means that around 5-6% of the UK population has type 2 diabetes. The annual incidence of type 2 diabetes in the UK has been steadily increasing, with an estimated 200,000 new cases diagnosed each year.

Omega-3 fatty acids may help improve insulin sensitivity, which is the ability of cells to respond to insulin and take up glucose from the bloodstream. Improved insulin sensitivity can help regulate blood sugar levels, which is important in managing type 2 diabetes. The growing need for omega-3 fatty acids influences the market growth.

China Non-Fish Omega 3 Supplements Market Analysis:

In China, the market is expected to grow to be worth US$ 71 million with an absolute dollar growth of US$ 40.5 million. The market in China has grown at a CAGR of 7.6% from 2018 to 2022 and is expected to grow at a CAGR of 8.8% from 2023 to 2033.

In 2018, infant formula sales were valued at around US$ 14 billion, while in 2020, the sales reached around US$ 15 billion. China was the largest user of infant formula products due to an increase in birth rates. DHA and EPA are important for the development of a baby’s brain and immune system. A high dose of DHA in infant formula helps with the growth of pre-term infants, such as an increase in height. The growing demand for infant formula products in China is the key driver of the non-fish omega 3 supplements market growth.

Japan Non-Fish Omega 3 Supplements Market Analysis:

In Japan, the market is expected to grow to be worth US$ 58.1 million, with an absolute dollar growth of US$ 30.9 million. The market in the country has grown at a CAGR of 6.7% from 2018 to 2022 and is expected to grow at a CAGR of 7.9% from 2023 to 2033.

In 2018, the retail sales of infant formula in Japan was valued at around US$ 2.07 billion. However, in 2020, the retail sales value of infant formula in the country was around US$ 1.92 billion. Changing consumer preferences, economic conditions, and government policies, can influence the growth of infant formulas in Japanese market. The growing need for infant formula in Japan is expected to contribute to market growth in the upcoming years.

India Non-Fish Omega 3 Supplements Market Analysis:

In India, the market is expected to grow to be worth US$ 35.5 million by 2033, with an absolute dollar growth of US$ 18.4 million. The market in India has grown at a CAGR of 6.1% from 2018 to 2022 and is expected to grow at a CAGR of 7.6% from 2023 to 2033.

According to the Food and Agriculture Organization (FAO) of the United Nations, in 2018, flaxseed production in India was around 80,000 metric tons, while in 2020 it increased from the previous year to 95,000 metric tons. Flaxseed is a rich plant-based source of omega-3 fatty acids, specifically alpha-linolenic acid (ALA), which is a type of polyunsaturated fatty acid. The growing production and consumption of omega-3 fatty acids contribute to the non-fish omega-3 supplements market share.

Category-Wise Insights

Why Capsules Form of Non-Fish Omega 3 Supplements is projected to Witness Significant Growth in the Market?

Non-Fish Omega 3 supplements in capsule form is projected to witness significant growth, as it has grown at a CAGR of 8% from 2018 to 2022 and is expected to grow at a CAGR of 9.2% from 2023 to 2033.

Capsules are one of the most common forms of delivery for Non-Fish Omega 3 supplements. They are easy to consume and convenient for consumers to take as a part of their daily routine. The market growth is mainly driven by an increasing awareness about the benefits of Non-Fish Omega 3 supplements, rising disposable incomes, and a growing preference for convenient and easy-to-use supplements.

Why Market through Pharma and Personal Care Applications is projected to Witness Significant Growth?

The market through pharma and personal care applications is projected to witness a CAGR of 7.8% from 2018 to 2022 and is expected to grow at a CAGR of 8.9% from 2023 to 2033.

Omega-3 fatty acids are essential nutrients that are beneficial for various health functions, including cardiovascular health, brain health, and inflammation regulation. Omega-3 supplements are available in different forms, including fish-derived and non-fish-derived sources such as algae, krill, and flaxseed.

The market for non-fish omega-3 supplements has been gaining traction in recent years, driven by factors such as increasing consumer awareness about the health benefits of omega-3s, growing demand for plant-based and sustainable alternatives, and advancements in omega-3 extraction and formulation technologies.

Competitive Analysis

Key players in the non-fish omega 3 supplements industry are Croda International Plc., Natural Products Drugs GmbH, Hero Nutritionals LLC, Koninklijke DSM N.V., Cargill, Inc., Epax Norway AS, Arista Industries Inc., Barleans Organic Oils LLC, Algaecytes Limited, Cellana Inc., AlgiSys, and Denomega Nutritional Oils.

A few of the recent developments in the market are:

• In June 2020, Cargill announced a joint venture with BASF, a global chemical company, to produce and market Omega 3 fatty acids from canola crops. This partnership is aimed to leverage Cargill's expertise in oilseed processing and BASF's expertise in microbial fermentation to develop a sustainable and scalable source of Omega 3 fatty acids.
• In October 2021, Nordic Naturals has entered the beauty market with new skin care supplements. Nordic Beauty Omega-3 + Borage Oil combines gamma linolenic acid (GLA) from borage seed oil and highly concentrated EPA+DHA from fish oil to support good skin and general wellness.

Segmentation of Non-Fish Omega 3 Supplements Market

• By Source :

  • Algae
  • Canola
  • Chia Seeds
  • Flax Seeds
  • Mustard
  • Other Sources

• By Form :

  • Capsules
  • Oils
  • Powder

• By Application :

  • Infant Formulas
  • Pharma & Personal

• By Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa